-31%

Custom Lens Fit: Personalize Your Vision with Your Own Frames - Send in Your Style for Perfect Eyewear

Regular price Rs. 3,299.00 INR
Sale price Rs. 4,800.00 INR
Style: Zero Power
Eyewear Type: Sleep Glasses

*If You have chosen Prescription Lens Please upload the Prescription Below.

*Note: Prescription glasses are usually delivered within 7-9 working days.

Sleepaxa Trust

SCIENCE & TRANSPARENCY
🔬  Spectrometer Lab Reports

All Sleepaxa lenses are tested using TM-3+ Spectrometer against ISO 12312-1, ANSI Z80.3, and AS/NZS 1067.1 standards.

Amber Sleep Lens
Parameter Value Status
Visible Light Transmittance 50.47% -
Blue Light Blocking (380-500nm) 99.87% PASS
480nm Melanopsin Peak 0.05% 99.95% BLOCKED
UV400 Protection 0.67% max PASS
UV-B (280-315nm) 0.01% PASS
UV-A (315-380nm) 0.08% PASS
View Amber Lab Report (PDF)
FL-41 Migraine Lens
Parameter Value Status
Visible Light Transmittance 41.10% -
FL-41 Band Filtration (480-520nm) ~12-13% FILTERED
Red Light Transmission (620-700nm) 87-100% HIGH
UV400 Protection 0.73% max PASS
UV-B (280-315nm) 0.00% PASS
UV-A (315-380nm) 0.08% PASS
View FL-41 Lab Report (PDF)
🎓  Sleepaxa Proprietary Research

Sleepaxa is the only Indian eyewear company with peer-reviewed published research on photobiological lens design.

Wavelength-Selective Filtration in Photobiological Eyewear

Dubey S, Choudhary M (2026) | Zenodo Technical Report | 46+ Views | 37+ Downloads

DOI: 10.5281/zenodo.19422123  |  Read on Academia.edu

ipRGC Subtypes, Signalling Pathways & Implications for Eyewear Design

Dubey S, Choudhary M (2026) | Zenodo Technical Report | 22 Peer-Reviewed References

DOI: 10.5281/zenodo.19500137  |  Read on Academia.edu

📜  Sleepaxa Patent Portfolio
GRANTED
NeuroCalm FLX+™

Indian Patent IN 202521094370 | All 10 Claims Approved

Dual-band selective light attenuation technology. Simultaneously filters 460-490nm (melanopsin/ipRGC pain pathway) and 585-600nm (cone-driven pain pathway) while preserving the beneficial 520-560nm green band. Addresses both migraine pain mechanisms identified by Harvard research (Noseda et al., 2016). India's first granted patent in photobiological eyewear.

PENDING
Circadian560™

Indian Patent Application IN 202521120977

Peak-blocking circadian protection technology. Achieves 100% attenuation of blue light at the melanopsin activation peak, with comprehensive blocking extending to the 560nm upper boundary of the melanopsin sensitivity envelope. Engineered for maximum melatonin protection during evening screen use, based on the published action spectrum (Brainard et al., 2001, Journal of Neuroscience).

Total IP Portfolio: 4 Patents (1 Granted + 3 Pending) | DPIIT Recognised Startup

✅  Company Credentials
Company Sleepaxa Private Limited
Founded 2023 | Mumbai, Maharashtra, India
Recognition DPIIT Recognised Startup | CTRI Registered

Suraj Dubey

Senior Optometrist, Researcher & Innovator

Founder & Head of R&D, Sleepaxa Private Limited. Inventor of NeuroCalm FLX+™ and Circadian560™. Named inventor on 4 Indian patents. Published researcher with peer-reviewed technical reports on photobiological lens design.

ORCID: 0009-0003-7510-9254

Dr. Monica Choudhary

Director MCVI | Ex-AIIMS Professor | Renowned Author & Optometrist

Founding Member, Clinical Advisory Board, Sleepaxa Private Limited. Former faculty at the All India Institute of Medical Sciences (AIIMS), New Delhi. Brings institutional-grade clinical oversight and academic rigour to all Sleepaxa lens technologies and published research.

Patents 4 Patents (1 Granted + 3 Pending)
Published Research 2 Technical Reports with DOI (Zenodo + Academia.edu)
Wikidata Entity Q138837663
Crunchbase Heat Score: 91
Close-up of a hand shaping an eyeglass lens using a high-precision lens cutting machine branded with SLEEPAXA, showcasing optical craftsmanship and advanced eyewear technology.
Custom Lens Fit: Personalize Your Vision with Your Own Frames - Send in Your Style for Perfect Eyewear
Regular price Rs. 3,299.00 INR
Sale price Rs. 4,800.00 INR

Unleash your individuality with Sleepaxa's revolutionary Custom Lens Fit service, where you can now bring your own frames to life with our exceptional lenses. Elevate your eyewear experience and enjoy a blend of style, comfort, and therapeutic relief.

Why Choose Sleepaxa's Custom Lens Fit:

Your Style, Your Way: Love your frames? Keep them! Our Custom Lens Fit allows you to use your favorite eyeglass frames, ensuring that your eyewear perfectly reflects your personal style.

Versatile Compatibility: From standard glasses frames to most specialty frames, we're here to make it work. Have a unique frame you adore? Send it our way, and we'll fit it with precision. For frame compatibility queries, reach out to us at connect@sleepaxa.com.

Therapeutic Excellence: Sleepaxa's Custom Lens Fit isn't just about style—it's about well-being. Enjoy the benefits of our therapeutic lenses, expertly crafted to filter out the most harmful wavelengths. Experience relief from light-triggered discomfort and enhance your visual comfort.

Personalized Protection: Whether you're dealing with light sensitivity, migraines, or other light-related issues, Sleepaxa's Custom Lens Fit ensures that your eyewear is tailored to provide the protection and relief you need.

How It Works:

Send In Your Frames: Ship your beloved frames to us, and let our expert technicians work their magic.

Precision Lens Fitting: Our skilled team will meticulously fit your frames with Sleepaxa's premium therapeutic lenses, ensuring optimal visual clarity and comfort.

Return of Your Customized Eyewear: Receive your personalized eyewear, ready to elevate your style and enhance your daily comfort.

Embrace the fusion of fashion and function with Sleepaxa's Personalized Lens Fit. Your frame, your style, your vision—because seeing is believing.

Get started today and rediscover the joy of personalized eyewear with Sleepaxa's Custom Lens Fit!

Recently Viewed

Don't forget! The products that you viewed. Add it to cart now.

People Also Bought

Here’s some of our most similar products people are buying. Click to discover trending style.